Search clinical trials for: BBI503
Total 35 results
-
Sumitomo Pharma America, Inc.CompletedCancer | Advanced Solid TumorsUnited States
-
Sumitomo Pharma America, Inc.TerminatedGastrointestinal Stromal TumorsCanada
-
Sumitomo Pharma America, Inc.WithdrawnRenal Cell Carcinoma | Urothelial Carcinoma | Urologic Malignancies
-
Sumitomo Pharma America, Inc.TerminatedCancer | Ovarian CancerUnited States
-
Sumitomo Pharma America, Inc.CompletedHepatocellular Carcinoma | CholangiocarcinomaCanada
-
Sumitomo Pharma America, Inc.CompletedHepatocellular CarcinomaUnited States
-
Sumitomo Pharma America, Inc.CompletedCancer, Advanced Solid TumorsUnited States, Canada
-
Sumitomo Pharma America, Inc.CompletedCancer, Advanced MalignanciesCanada, United States
-
Blueberry TherapeuticsIQVIA BiotechCompletedA Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the ToenailFungal Infection | Distal Subungual Onychomycosis | Fungus, NailPoland, Germany, Czechia
-
Sumitomo Pharma America, Inc.CompletedHealthy | ADMEUnited States
-
Sumitomo Pharma Co., Ltd.CompletedHepatocellular Carcinoma | Advanced Solid TumorsJapan
-
Xiangya Hospital of Central South UniversityNot yet recruitingParkinson's DiseaseChina
-
ABL Bio, Inc.Recruiting
-
NCIC Clinical Trials GroupSumitomo Pharma Oncology, Inc.CompletedColorectal CarcinomaCanada, Australia, Japan
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Sumitomo Pharma America, Inc.CompletedCancerCanada, United States
-
Sumitomo Pharma America, Inc.CompletedDrug-drug InteractionsUnited States
-
Sumitomo Pharma Co., Ltd.CompletedHepatocellular CarcinomaJapan
-
Teva Pharmaceuticals USACompletedHealthyUnited States, Canada
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Sanofi; Cytogen CorporationCompletedProstate CancerUnited States
-
Sumitomo Pharma America, Inc.CompletedGlioblastomaUnited States, Canada
-
Sumitomo Pharma America, Inc.Terminated
-
Sumitomo Pharma Co., Ltd.CompletedNon-Small Cell Lung Cancer | Malignant Pleural MesotheliomaJapan
-
Sumitomo Pharma America, Inc.CompletedGastric Cancer | Gastroesophageal Junction CancerUnited States, Hungary, Spain, China, Brazil, France, Australia, Czechia, Germany, Israel, Canada, United Kingdom, Japan, Belgium, Romania, Italy, Poland, Lithuania, Korea, Republic of, Bulgaria, Estonia, Russian Federation
-
Sumitomo Pharma America, Inc.CompletedCancerUnited States, Canada
-
Australasian Gastro-Intestinal Trials GroupCompleted
-
Sumitomo Pharma America, Inc.Completed
-
Sumitomo Pharma America, Inc.Completed
-
Sumitomo Pharma America, Inc.CompletedCarcinoma, Pancreatic DuctalUnited States, France, Netherlands, Spain, Taiwan, China, Belgium, Korea, Republic of, Austria, Singapore, Japan, Italy, Germany, Portugal, Poland, Czechia, Australia, Canada, Russian Federation, Ukraine
-
Sumitomo Pharma Co., Ltd.CompletedMetastatic Colorectal CancerJapan
-
Sumitomo Pharma America, Inc.CompletedHematologic MalignancyUnited States
-
Sumitomo Pharma America, Inc.CompletedColorectal CancerUnited States, Canada, Spain, Australia, China, Hong Kong, Israel, Czechia, France, Japan, Belgium, Germany, Netherlands, Italy, Korea, Republic of, Singapore
-
Sumitomo Pharma America, Inc.CompletedAdvanced Gastrointestinal CancerUnited States, Canada
-
Sumitomo Pharma America, Inc.CompletedOncologyUnited States, Taiwan, Japan, France
-
Sumitomo Pharma America, Inc.CompletedMetastatic Pancreatic AdenocarcinomaUnited States